Biotech · Private company
Alar Pharmaceuticals Inc.
Track this companyFree. Adds Alar Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ALA-1000Phase 1 · Opioid-use DisorderClinicalTrials.gov · fetched Nov 12, 2026
- ALA-3000Phase 1 · Treatment Resistant DepressionClinicalTrials.gov · fetched Nov 12, 2026
- buprenorphine sublingual filmPhase 1 · Opioid-use DisorderClinicalTrials.gov · fetched Nov 12, 2026
- escitalopram, sertraline, duloxetine or venlafaxine XRPhase 1 · Treatment Resistant DepressionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Multiple Ascending Dose Phase 1 Study of ALA-3000PHASE1 · COMPLETED · started Apr 21, 2025ClinicalTrials.gov NCT06965569 · fetched Nov 12, 2026
- Single Ascending Dose Study of ALA-1000PHASE1 · COMPLETED · started Sep 16, 2019ClinicalTrials.gov NCT04122755 · fetched Nov 12, 2026